NK-cell purging of leukemia

Superior antitumor effects of NK cells H2 allogeneic to the tumor and augmentation with inhibitory receptor blockade

Crystal Y. Koh, John R. Ortaldo, Bruce R. Blazar, Michael Bennett, William J. Murphy

Research output: Contribution to journalArticle

30 Citations (Scopus)

Abstract

Natural killer (NK) cells are composed of subsets characterized by the expression of inhibitory or activating receptors, or both, specific for different major histocompatibility complex (MHC) class I determinants. We have previously shown that inhibitory receptor blockade of syngeneic NK cells was an effective means of ex vivo purging of leukemia-contaminated bone marrow and that the transplantation of mice with the purged bone marrow cells (BMCs) resulted in long-term, relapse-free survival. We have extended the investigation to assess the antitumor effects mediated by NK cells H2-allogeneic to tumor cells. We demonstrate that various tumor cell lines are more susceptible to lysis by H2-allogeneic NK cells than by syngeneic NK cells in vitro even though comparable percentages of Ly49 NK cells were present. Using allogeneic NK cells to purge leukemia-contaminating BMCs before transplantation resulted in a higher proportion of mice with long-term survival than using syngeneic NK cells. Allogeneic NK cells did not suppress hematopoietic reconstitution as measured by granulocyte/monocyte-colony-forming unit (CFU-GM), complete blood count (CBC), and donor chimerism at various days after transplantation. Inhibitory receptor blockade of allogeneic NK cells also significantly increased these antitumor effects at lower NK/tumor ratios compared with those of syngeneic NK cells. These results demonstrate that H2-allogeneic NK celis mediate more potent antitumor effects than syngeneic NK cells without adverse hematologic effects and thus may be useful in cancer therapy.

Original languageEnglish
Pages (from-to)4067-4075
Number of pages9
JournalBlood
Volume102
Issue number12
DOIs
Publication statusPublished - Dec 1 2003

Fingerprint

Purging
Natural Killer Cells
Tumors
Bone
Leukemia
Cells
Neoplasms
Blood
Bone Marrow Transplantation
Granulocyte-Macrophage Progenitor Cells
Chimerism
Blood Cell Count
Tumor Cell Line
Major Histocompatibility Complex
Blood Donors
Granulocytes
Bone Marrow Cells
Monocytes
Stem Cells

ASJC Scopus subject areas

  • Immunology
  • Biochemistry
  • Hematology
  • Cell Biology

Cite this

NK-cell purging of leukemia : Superior antitumor effects of NK cells H2 allogeneic to the tumor and augmentation with inhibitory receptor blockade. / Koh, Crystal Y.; Ortaldo, John R.; Blazar, Bruce R.; Bennett, Michael; Murphy, William J.

In: Blood, Vol. 102, No. 12, 01.12.2003, p. 4067-4075.

Research output: Contribution to journalArticle

Koh, Crystal Y. ; Ortaldo, John R. ; Blazar, Bruce R. ; Bennett, Michael ; Murphy, William J. / NK-cell purging of leukemia : Superior antitumor effects of NK cells H2 allogeneic to the tumor and augmentation with inhibitory receptor blockade. In: Blood. 2003 ; Vol. 102, No. 12. pp. 4067-4075.
@article{e92539b4e9564efa9fc0791b04170d83,
title = "NK-cell purging of leukemia: Superior antitumor effects of NK cells H2 allogeneic to the tumor and augmentation with inhibitory receptor blockade",
abstract = "Natural killer (NK) cells are composed of subsets characterized by the expression of inhibitory or activating receptors, or both, specific for different major histocompatibility complex (MHC) class I determinants. We have previously shown that inhibitory receptor blockade of syngeneic NK cells was an effective means of ex vivo purging of leukemia-contaminated bone marrow and that the transplantation of mice with the purged bone marrow cells (BMCs) resulted in long-term, relapse-free survival. We have extended the investigation to assess the antitumor effects mediated by NK cells H2-allogeneic to tumor cells. We demonstrate that various tumor cell lines are more susceptible to lysis by H2-allogeneic NK cells than by syngeneic NK cells in vitro even though comparable percentages of Ly49 NK cells were present. Using allogeneic NK cells to purge leukemia-contaminating BMCs before transplantation resulted in a higher proportion of mice with long-term survival than using syngeneic NK cells. Allogeneic NK cells did not suppress hematopoietic reconstitution as measured by granulocyte/monocyte-colony-forming unit (CFU-GM), complete blood count (CBC), and donor chimerism at various days after transplantation. Inhibitory receptor blockade of allogeneic NK cells also significantly increased these antitumor effects at lower NK/tumor ratios compared with those of syngeneic NK cells. These results demonstrate that H2-allogeneic NK celis mediate more potent antitumor effects than syngeneic NK cells without adverse hematologic effects and thus may be useful in cancer therapy.",
author = "Koh, {Crystal Y.} and Ortaldo, {John R.} and Blazar, {Bruce R.} and Michael Bennett and Murphy, {William J.}",
year = "2003",
month = "12",
day = "1",
doi = "10.1182/blood-2003-04-1367",
language = "English",
volume = "102",
pages = "4067--4075",
journal = "Blood",
issn = "0006-4971",
publisher = "American Society of Hematology",
number = "12",

}

TY - JOUR

T1 - NK-cell purging of leukemia

T2 - Superior antitumor effects of NK cells H2 allogeneic to the tumor and augmentation with inhibitory receptor blockade

AU - Koh, Crystal Y.

AU - Ortaldo, John R.

AU - Blazar, Bruce R.

AU - Bennett, Michael

AU - Murphy, William J.

PY - 2003/12/1

Y1 - 2003/12/1

N2 - Natural killer (NK) cells are composed of subsets characterized by the expression of inhibitory or activating receptors, or both, specific for different major histocompatibility complex (MHC) class I determinants. We have previously shown that inhibitory receptor blockade of syngeneic NK cells was an effective means of ex vivo purging of leukemia-contaminated bone marrow and that the transplantation of mice with the purged bone marrow cells (BMCs) resulted in long-term, relapse-free survival. We have extended the investigation to assess the antitumor effects mediated by NK cells H2-allogeneic to tumor cells. We demonstrate that various tumor cell lines are more susceptible to lysis by H2-allogeneic NK cells than by syngeneic NK cells in vitro even though comparable percentages of Ly49 NK cells were present. Using allogeneic NK cells to purge leukemia-contaminating BMCs before transplantation resulted in a higher proportion of mice with long-term survival than using syngeneic NK cells. Allogeneic NK cells did not suppress hematopoietic reconstitution as measured by granulocyte/monocyte-colony-forming unit (CFU-GM), complete blood count (CBC), and donor chimerism at various days after transplantation. Inhibitory receptor blockade of allogeneic NK cells also significantly increased these antitumor effects at lower NK/tumor ratios compared with those of syngeneic NK cells. These results demonstrate that H2-allogeneic NK celis mediate more potent antitumor effects than syngeneic NK cells without adverse hematologic effects and thus may be useful in cancer therapy.

AB - Natural killer (NK) cells are composed of subsets characterized by the expression of inhibitory or activating receptors, or both, specific for different major histocompatibility complex (MHC) class I determinants. We have previously shown that inhibitory receptor blockade of syngeneic NK cells was an effective means of ex vivo purging of leukemia-contaminated bone marrow and that the transplantation of mice with the purged bone marrow cells (BMCs) resulted in long-term, relapse-free survival. We have extended the investigation to assess the antitumor effects mediated by NK cells H2-allogeneic to tumor cells. We demonstrate that various tumor cell lines are more susceptible to lysis by H2-allogeneic NK cells than by syngeneic NK cells in vitro even though comparable percentages of Ly49 NK cells were present. Using allogeneic NK cells to purge leukemia-contaminating BMCs before transplantation resulted in a higher proportion of mice with long-term survival than using syngeneic NK cells. Allogeneic NK cells did not suppress hematopoietic reconstitution as measured by granulocyte/monocyte-colony-forming unit (CFU-GM), complete blood count (CBC), and donor chimerism at various days after transplantation. Inhibitory receptor blockade of allogeneic NK cells also significantly increased these antitumor effects at lower NK/tumor ratios compared with those of syngeneic NK cells. These results demonstrate that H2-allogeneic NK celis mediate more potent antitumor effects than syngeneic NK cells without adverse hematologic effects and thus may be useful in cancer therapy.

UR - http://www.scopus.com/inward/record.url?scp=0344826089&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0344826089&partnerID=8YFLogxK

U2 - 10.1182/blood-2003-04-1367

DO - 10.1182/blood-2003-04-1367

M3 - Article

VL - 102

SP - 4067

EP - 4075

JO - Blood

JF - Blood

SN - 0006-4971

IS - 12

ER -